Serially innovating to create potentially transformative solutions for patients is the mission that drives everything we do at Vertex. So we’re delighted that our 20 years of innovation have been recognized in the 2024 Prix Galien International Awards for our work in Orphan/Rare Diseases, discovering and developing options for patients living with cystic fibrosis.
Well deserved! The treatment for Cystic Fibrosis has come a long way since I took care of patients at Boston Children’s in the 1980’s!
Dedication. There are so many patients with unmet need out there. But effective, safe life altering treatments take resilience, tenacity and the creativity of scientists, and the trust, belief and focus of investors to make this happen. Congratulations Vertex Pharmaceuticals and to all involved.
Congratulations on this well-deserved recognition, Vertex! Your commitment to innovation in rare diseases is truly inspiring.
Congratulations to Vertex Pharmaceuticals on being recognized at the 2024 Prix Galien International Awards for your groundbreaking work in orphan and rare diseases! Your commitment to innovation and developing transformative solutions for patients with cystic fibrosis is truly inspiring. Keep up the amazing work! 🌟 #Innovation #CysticFibrosis #PrixGalienAwards
Congrats....CF is a horrible disease! Thanks for all that you do!
Excellent
Wonderful work that also gives lifetime